Practice Bulletins are evidence-based documents that summarize current Number , May ) (Interim Update); Cervical Cancer Screening and. The incidence of cervical cancer in the United States has decreased more than 50% in the past 30 years because of widespread screening with cervical cytology . COMMITTEE ON PRACTICE BULLETINS—Gynecology Practice Screening and Prevention (Replaces Practice Bulletin Number , Full text of Practice Bulletin #, an interim update of #, is available to ACOG.
|Published (Last):||1 September 2015|
|PDF File Size:||4.83 Mb|
|ePub File Size:||13.56 Mb|
|Price:||Free* [*Free Regsitration Required]|
Using the screening recommendations applicable at the time of the surveys, 1 we defined responses for timing of the next Papanicolaou test as consistent with guidelines; sooner than recommended; and later than recommended Table 1 and Table 2.
Create a personal account to register for email alerts with links to free full-text articles. Drafting of the manuscript: Byit had been reduced to 6. The highest adherence to guidelines occurred when the recommended interval was less than 3 years, suggesting that clinicians are willing to adhere to guidelines if more vigilant testing is recommended.
Cervical Cancer Screening Intervals, to Centers for Disease Screeinng and Prevention.
Create a free personal account to make a comment, download free article PDFs, sign up for alerts and more. A novel benefit of co-testing is the ability to extend screening intervals immediately among women who have no prior screening or whose screening history is unavailable if both test results are normal, yet the lowest adherence to guidelines was for the vignette of a woman with unknown Papanicolaou test history and negative co-test results 3.
Purchase access Subscribe to the journal. Back to top Article Information.
Purchase access Subscribe to JN Learning for one year. In vignette 4, sceening increased from Clinical guidelines recommend that women 30 years and older with a negative test result for oncogenic human papillomavirus HPV and with a concurrent normal Papanicolaou test result co-testing not be tested again for at least 3 years. Accessed December 12, The ability to obtain prior screening results and the use of electronic medical records or systems changes, such as office reminders or reimbursement packages, may help achieve adherence to recommended intervals.
Screening for cervical cancer: Sign in to save your search Sign bulletln to your personal account. In addition, there are different risk-benefit considerations for women at different ages, as reflected in age-specific screening recommendations.
New technologies for cervical cancer screening continue to evolve as do recommendations for managing the results. Sign in to access your subscriptions Sign in to your personal account. Inthe rate was Future analyses will monitor adherence to newer guidelines that recommend extending screening intervals to 5 years among women with normal co-testing results, a strategy designed to achieve a reasonable balance between benefits and harms.
Get free access to newly published articles. Each vignette included Papanicolaou test results in the prior 5 years and current HPV and Papanicolaou test results. Moving Beyond Annual Testing.
Create a free personal account to download free article PDFs, dor up for alerts, customize your interests, and more. Mortality from the disease has undergone a similar decrease from 5.
Guideline adherence was low overall, especially in vignettes portraying women with normal test results vignettes 1, 2, and 3. Uncertain concordance of practitioner response to hypothetical vignette with actual practice might also be of concern.
About the ambulatory health care surveys: Purchase access Subscribe now. Cervical cancer is much practicf common worldwide, particularly in countries without screening programs, with an estimatednew cases of the disease andresultant deaths each year 3, 4. Sign in to download free article PDFs Sign in to access your subscriptions Sign in to your personal account.